✦ LIBER ✦

Quest for Cure: UK Children's Cancer Study Group?the first 25 years

✍ Scribed by Vietti, Teresa J.

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 29 KB
Volume: 41
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.10367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective adjuvant therapy with Mitomy

Prospective adjuvant therapy with Mitomycin C and Carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer

✍ Ito, Katsuki; Yamaguchi, Akihiro; Miura, Kaoru; Kato, Tomoyuki; Koike, Akihiko; 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 2 views

A joint study was performed by the Tokai HCFU study group, which included 41 institutions to study the usefulness of the concomitant therapy with Mitomycin C (MMC) and Carmofur (HCFU) as a postoperative adjuvant chemotherapy in patients with colorectal cancer who had curative resection. Patients wer

A Phase II study of carboplatin as a tre

A Phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow : A report of the Children's Cancer Group

✍ Lawrence J. Ettinger; Percy Ivy; Paul S. Gaynon; Alice G. Ettinger; Wen Liu-Mare 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 3 views

## BACKGROUND. Carboplatin is an analogue of cisplatin with less nonhematologic toxicity

Bone marrow transplantation versus chemo

Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: A study of the children's cancer group (CCG-1884)

✍ Feig, Stephen A.; Harris, Richard E.; Sather, Harland N. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 3 views

Background. Maintenance of second remission of childhood acute lymphoblastic leukemia (ALL) with intensive chemotherapy is often unsuccessful. The major cause of treatment failure is relapse. Materials and Methods. Of 96 children with ALL who relapsed in the marrow while on or within 1 year of comp

Granulocyte-macrophage colony-stimulatin

Granulocyte-macrophage colony-stimulating factor in association with high-dose chemotherapy (VETOPEC) for childhood solid tumors: A report from the Australia and New Zealand Children's Cancer Study Group

✍ McCowage, Geoffrey B.; White, Les; Carpenter, Paul; Lockwood, Lianne; Toogood, I 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

## Purpose: Combination chemotherapy with vincristine, etoposide, and high-dose, escalating cyclophosphamide (vetopec) is an effective regimen in pediatric patients with high-risk solid tumors. the toxicity of the regimen is predominantly haematologic. this study addressed the role of recombinant h

A dose-intensive, cyclophosphamide-based

A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group

✍ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.

A Phase I study of granulocyte-macrophag

A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors : A report of the Children's Cancer Group

✍ Mitchell S. Cairo; Mark D. Krailo; Joel A. Weinthal; Rita Secola; Sharon Bergero 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 3 views

## Background: This phase i trial was developed to determine the safety, biologic activity, and effects on hematopoietic recovery of pixy321 following ifosfamide, carboplatin, and etoposide chemotherapy for children with recurrent or refractory solid tumors. ## Methods: Children (age < 22 years a